Arca
Skip to content

i-STAT PTplus Cartridge with the i-STAT 1 System

Test, Time, Prothrombin. 510(k) K220282, from Abbott Laboratories (Princton, NJ). Product code GJS, class 2.

As of Nov 17, 2026, K220282 is an FDA 510(k) held by Abbott Laboratories, substantially equivalent on Jul 14, 2023 after 528 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jul 14, 2023
  • Review time: 528 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The i-STAT PT$^{plus}$ cartridge is intended for use in the in vitro quantitative measurement of the clot time of the extrinsic coagulation pathway when activated by thromboplastin in non-anticoagulated whole blood (venous or capillary), using the i-STAT 1 System.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other GJS Clearances

The newest 510(k)s for the same product code; their median review was 104 days; see every GJS device

Record

Type
Traditional
Received
Feb 1, 2022
Review panel
Hematology
Regulation
21 CFR 864.7750

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.